Enhancing ties between academia and industry to improve health | Zendy

S. Claiborne Johnston | Zendy; Stephen L. Hauser | Zendy; Susan Desmond-Hellmann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Enhancing ties between academia and industry to improve health

Author(s) -

S. Claiborne Johnston,

Stephen L. Hauser,

Susan Desmond-Hellmann

Publication year - 2011

Publication title -

nature medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.536

H-Index - 547

eISSN - 1546-170X

pISSN - 1078-8956

DOI - 10.1038/nm0411-434

Subject(s) - pharmaceutical industry , conflict of interest , investment (military) , business , affect (linguistics) , drug industry , public relations , marketing , industrial organization , public economics , economics , political science , engineering ethics , medicine , finance , engineering , sociology , communication , politics , law , pharmacology

Concerns about conflicts of interest have driven a wedge between academia and the pharmaceutical and devices industries. Although elevated concern for bias is justified, particularly when academics may affect drug sales, partnerships between industry and academia are essential to achieve the full promise of health improvement from the public investment in biomedical research. New models for such partnerships are developing and should be encouraged.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research